Dietmar Hopp (Photo by: Uwe Anspach/picture-alliance/dpa/AP Images)
In all-encompassing rights deal with Huadong, Dietmar Hopp's Heidelberg looks to bring its ADCs to most of Asia
Just a few days after German billionaire investor Dietmar Hopp sunk some of his cash into Heidelberg Pharma, the biotech is celebrating a new licensing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.